Beckwith-Wiedemann syndrome (BWS) is characterized by numerous growth
abnormalities and an increased risk of childhood tumors. The gene for
BWS is localized in the 11p15.5 region, as determined by linkage analy
sis of autosomal dominant pedigrees. The increased maternal transmissi
on pattern seen in the autosomal dominant-type pedigrees and the findi
ngs of paternal uniparental disomy reported for a subgroup of patients
indicate that the gene for BWS is imprinted, Previously, we found p57
(KIP2), which is a Cdk-kinase inhibitor located at 11p15, is mutated i
n two BWS patients. Here, we screened for the mutation of the gene in
15 BWS patients.